Characteristics of Clinical Laboratory Indicators in Patients with Dengue Fever
Launched by FOSHAN HOSPITAL OF TRADITIONAL CHINESE MEDICINE · Mar 13, 2025
Trial Information
Current as of April 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- * Inclusion Criteria\*\*:
- • Meet the clinical diagnostic criteria for dengue fever, with blood indicators showing that the dengue antigen is positive.
- • No age limit for inclusion.
- • Voluntarily agree to participate in the study and sign the informed consent.
- • Complete clinical data available, including symptoms and laboratory tests, to support subsequent analysis.
- * Exclusion Criteria\*\*:
- • Incomplete or unavailable clinical data. Patients will be excluded if sufficient laboratory data and symptoms cannot be collected.
- • Unable to understand or unwilling to sign the informed consent for any reason.
About Foshan Hospital Of Traditional Chinese Medicine
Foshan Hospital of Traditional Chinese Medicine is a distinguished healthcare institution dedicated to the integration of traditional Chinese medicine (TCM) with modern medical practices. Renowned for its commitment to patient-centered care, the hospital specializes in a wide range of therapeutic modalities, including acupuncture, herbal medicine, and holistic treatment approaches. As a clinical trial sponsor, Foshan Hospital actively contributes to advancing TCM through rigorous research and innovative clinical studies aimed at validating the efficacy and safety of traditional therapies. With a focus on enhancing health outcomes and broadening the understanding of TCM, the hospital fosters collaboration with researchers and healthcare professionals to promote evidence-based practices in the field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Foshan, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported